Drug Type Bispecific antibody |
Synonyms |
Target |
Action inhibitors |
Mechanism CD28 inhibitors(T-cell-specific surface glycoprotein CD28 inhibitors), OX40 inhibitors(Tumor necrosis factor receptor superfamily member 4 inhibitors) |
Therapeutic Areas |
Active Indication |
Inactive Indication- |
Indication | Highest Phase | Country/Location | Organization | Date |
---|---|---|---|---|
Inflammation | Phase 1 | - | - |